Perioperative beta blockers for patients with Diabetes - Letters to the Editor - Letter to the Edito

Date: Sept 1, 2003

TO THE EDITOR: I found Dr. Marks' article, "Perioperative Management of Diabetes," (1) to be a useful guide for the perioperative management of diabetic medications. Because diabetes is a significant risk factor for cardiac complications, it is important to remind readers that perioperative beta blockers are often indicated in these patients. The use of a perioperative beta blocker in patients with major risk factors for coronary artery disease is a class IIa recommendation by the American College of Cardiology/American Heart Association. (2) An excellent review (3) on the indications, contraindications, and methods of perioperative beta blockade was published recently. Diabetes mellitus requiring insulin therapy is a Cardiac Risk Index Criteria and is an indication for beta blockade. Diabetes that does not require insulin is a minor criteria, and, in conjunction with age greater than 65 years, hypertension, current smoking, or total cholesterol level more than 240, also is an indication for beta blockade.

M. Lee Chambliss, M.D., M.S.P.H.

Moses Cone Family Medicine Residency

1125 N. Church St.

Greensboro, NC 27401

REFERENCES

(1.) Marks JB. Perioperative management of diabetes. Am Fam Physician 2003;67:93-100.

(2.) Eagle KA, Gibbons RJ, Antman EM, Berger PB, Calkins H. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at: www.acc.org/clinical/ guidelines/perio/update/pdf/perio_update.pdf.

(3.) Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435-44.

IN REPLY: Dr. Chambliss makes an important point. However, discussion of the use of any medications, other than those directed at maintaining glycemic and metabolic homeostasis in the diabetic perioperative patient, was beyond the scope of my paper. I agree with the use of beta blockers in patients with diabetes who require insulin and are at risk for coronary artery disease. Dr. Chambliss' reminder to review this separate topic is timely.

Jennifer B. Marks, M.D.

University of Miami School of Medicine

P.O. Box 016960 (D-110)

Miami, FL 33101

COPYRIGHT 2003 American Academy of Family PhysiciansCOPYRIGHT 2003 Gale Group

 
© 2006, DrPlace.com, All Rights Reserved.